Nanosonics Jumps on Earnings Beat, In-Line Guidance -- Market Talk

Dow Jones
Aug 26

0036 GMT - Nanosonics rises 11% to A$4.57 following its annual result, with RBC Capital Markets calling it a relief rally as shares in the medical-device maker had been weak for a while. Nanosonics reported an underlying net profit of A$20.7 million in FY 2025, above RBC's A$17.7 million forecast. It also provided maiden revenue guidance of A$215 million-A$223 million for FY 2026, implying 8-12% growth, along with other forecasts. "Management's guidance includes A$4 million of tariff impact, although there are some mitigation strategies expected to offset the majority of tariff impact at the pretax profit level," says analyst Craig Wong-Pan. Nanosonics is on course for its best close since mid-May. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

August 25, 2025 20:36 ET (00:36 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10